Skip to main content
Clinical Trials/ChiCTR2500101672
ChiCTR2500101672Not yet recruitingNot Applicable

甲磺酸萘莫司他与枸橼酸用于连续肾脏替代治疗抗凝效果的比较:一项回顾性队列研究

自选课题(自筹)1 site in 1 countryStarted: April 1, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Locations
1
Primary Endpoint
滤器寿命

Study Overview

Brief Summary

比较萘莫司他和枸橼酸用于 CRRT 抗凝对滤器寿命的影响,以及经济学效益差别

Study Design

Study Type
观察性研究
Primary Purpose
队列研究
Masking

Eligibility Criteria

Ages
18 to — (—)
Sex
All

Inclusion Criteria

  • 1.患者年龄≥18 岁;
  • 2.CRRT 计划时间为 72 小时患者;

Exclusion Criteria

  • 72 内小时主动下机患者(包括目标达成或因病情变化死亡等主动下机);
  • 2.因透析导管原因导致下机患者;
  • 3.未记录下机原因的患者;
  • 4.联合其他血液净化方式患者;
  • 5.未使用单一抗凝剂的患者;

Arms & Interventions

萘莫司他组

枸橼酸钠组

Outcomes

Primary Outcomes

滤器寿命

Time Frame: CRRT 开始后 72 小时内

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
自选课题(自筹)

Study Sites (1)

Loading locations...

Similar Trials